Lavie Bio to Host a Round Table Discussion and is a Sponsor at World Agri-Tech Conference in San Francisco

Rhea-AI Summary

Lavie Bio, a subsidiary of Evogene (Nasdaq: EVGN), announced its participation at the World Agri-Tech Conference in San Francisco on March 14-15, 2023. The company will host a roundtable discussion entitled 'Farm to Fork or Fork to Farm' on March 15, focusing on the sustainability value chain. Lavie Bio is also a sponsor of the conference, which attracts over 2,000 participants from the global ag-tech ecosystem. The company aims to enhance food quality and agricultural productivity through microbiome-based products, leveraging its MicroBoost AI tech-engine.

News Market Reaction – EVGN

-5.09%

1 alert

-5.09% News Effect

On the day this news was published, EVGN declined 5.09%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

REHOVOT, Israel, March 6, 2023 /PRNewswire/ --  Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), and a leading ag-biological company focusing on improving food quality, sustainability, and agriculture productivity through the introduction of microbiome-based products, today announced in that its management will be sponsoring and participating at the World Agri-Tech Conference in San Francisco, taking place between March 14-15, 2023.

Lavie Bio's EVP Commercial & US General Manager, Russ Putland, will be hosting a lunchtime roundtable discussion on March 15, entitled, "Farm to Fork or Fork to Farm", taking place during the conference. The discussion will focus into aspects of the sustainability value chain, starting with the consumer right down to the farmgate.

Lavie Bio is a one of the sponsors of the World Agri-Tech Innovation Summit, in company with some of the world leading technology companies as well as key ag-tech players. The Summit has become the annual meeting place for the global ag-tech ecosystem, with over 2,000 growers, agribusiness leaders, technology pioneers and investors coming together to exchange insights, be inspired, and identify future partners.

Investors or analysts attending the conference and wish to meet with the management of Lavie Bio and Evogene, are welcome to contact the Lavie Bio team or reach out through World Agri-Tech conference channels.

About Lavie Bio Ltd.

Lavie Bio, a subsidiary of Evogene Ltd., aims to improve food quality, sustainability, and agriculture productivity through the introduction of microbiome-based ag-biological products. Lavie Bio utilizes a proprietary computational predictive platform, the BDD platform, powered by Evogene's proprietary MicroBoost AI tech-engine, harnessing the power of big data, artificial intelligence, and advanced informatics, for the discovery, optimization and development of bio-stimulant and bio-pesticide products.

For more information, please visit www.lavie-bio.com.

About Evogene Ltd.:

Evogene (Nasdaq: EVGN, TASE: EVGN) is a computational biology company aiming to revolutionize the development of life-science based products by utilizing cutting edge technologies to increase the probability of success while reducing development time and cost. Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI – leveraging Big Data and Artificial Intelligence and incorporating deep multidisciplinary understanding in life sciences. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).

Evogene uses its tech-engines to develop products through subsidiaries and strategic partnerships. Evogene's subsidiaries currently utilize the tech-engines to develop human microbiome-based therapeutics by Biomica, ag-biologicals by Lavie Bio, ag-chemicals by AgPlenus, medical cannabis products by Canonic and castor varieties, for the biofuel and other industries, by Casterra. 

For more information, please visit www.evogene.com 

Contacts
Russ Putland, EVP Commercial & GM USA E: russel.putland@lavie-bio.com T: +1 980 474 8170	Dor Kestecher, VP Business Development E: dor.kestecher@lavie-bio.com T: +972 52 363 3684
Kenny Green, Investor Relations E: kenny.green@evogene.com    T: +1 212 378 8040

Logo:  https://mma.prnewswire.com/media/945133/lavie_bio.jpg
Logo: https://mma.prnewswire.com/media/1947468/Evogene.jpg

 

View original content:https://www.prnewswire.com/news-releases/lavie-bio-to-host-a-round-table-discussion-and-is-a-sponsor-at-world-agri-tech-conference-in-san-francisco-301763156.html

SOURCE Lavie Bio

FAQ

What event is Lavie Bio participating in on March 14-15, 2023?

Lavie Bio is participating in the World Agri-Tech Conference in San Francisco.

What discussion will Lavie Bio host during the World Agri-Tech Conference?

Lavie Bio will host a discussion titled 'Farm to Fork or Fork to Farm' focusing on sustainability.

Who from Lavie Bio will lead the roundtable discussion?

Russ Putland, EVP Commercial & US General Manager, will lead the roundtable discussion.

What is the focus of Lavie Bio's products?

Lavie Bio focuses on improving food quality and agricultural productivity through microbiome-based products.

What technology does Lavie Bio utilize in its product development?

Lavie Bio utilizes the MicroBoost AI tech-engine for developing ag-biological products.